Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak (michal.masternak@ucf.edu) for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 16, Number 5, 2011

Bladder preservation by concurrent chemoradiation for muscle-invasive bladder cancer: Applicability in low-income countries

Jamal Khader, Naim Farah, Ahmed Salem

Summary:

Background: Radical cystectomy is the standard treatment for patients withmuscle-invasive
urinary bladder cancer; however, is associated with major treatment – related morbidity.
Furthermore, a significant proportion of patients are deemed unsuitable for surgery due
to inoperability, advanced age, and/or comorbid conditions. As such, several groups have
explored effectiveness of less radical therapeutic strategies that aim at bladder preservation.
Nonetheless, there is scarcity of reports assessing the applicability of urinary bladdersparing
outside developed countries.
Aim: Determine the achievable outcomes for patients with muscle-invasive urinary bladder
cancer treated via bladder-sparing techniques in a low income country.
Materials and methods: Fourteen consecutive patients with a diagnosis ofmuscle-invasive urinary bladder cancer (clinical stage; T2-3N0M0) were treated via a bladder-sparing approach
at King Hussein Cancer Center (Amman, Jordan) between 2005 and 2009. Records were electronically retrieved and retrospectively analyzed and included 11 males and 3 females from 41 to 74 years of age (median age, 61). Initial therapy consisted of trans-urethral resection of bladder tumor (TURBT) followed by induction chemotherapy then irradiation (4500cGy) with concurrent platinum-based chemotherapy. Urological evaluation directed additional therapy in a proportion of patients with irradiation (up to 6400 cGy) in patients who
achieved CR.
Results: Eleven patients were evaluable for pathological response at time of re-staging; of
whom 8 (73%) achieved CR and 3 (27%) achieved partial response (PR). In all but one patient;
combined-modality treatment was well tolerated. After a median follow-up of 18.5 months
(range, 3–48 months); 5 of 8 (62.5%) patients with CR were alive.
Conclusions: Bladder-sparing strategies via concurrent chemoradiation for muscle-invasive
bladder cancer results in an acceptable rate of complete pathological response with adequate
short-term outcomes. This approach appears applicable in low-income countries.

Signature: Rep Pract Oncol Radiother, 2011; 16(5) : 178-183


« back

 
INDEXED IN:

Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.

http://www.sciencedirect.com/science/journal/15071367/19/2